NCT00372827

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Efficacy and Safety of Timolol Maleate 0.5% Compared to Brinzolamide 1% When Added to Travoprost 0.004% in Primary Open-angle Glaucoma or Ocular Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 245 (planned)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to compare the efficacy and safety of Timolol 0.5% solution to Brinzolamide 1% each given twice daily when added to Travoprost 0.004% given each evening.

Conditions

• Primary Open-angle Glaucoma
• Ocular Hypertension
• Pigment Dispersion Glaucoma

Interventions

Type	Name	Description
DRUG	Brinzolamide 1% added to Travoprost 0.004%

Timeline

• Start date: 2004-02-01
• Primary completion: 2006-01-01
• Completion: 2006-01-01
• First posted: 2006-09-07
• Last updated: 2016-11-21

Locations

1 site across 1 country: Germany